Upadacitinib Salvage Therapy for Infliximab-Experienced Patients with Acute Severe Ulcerative ColitisRobert Gilmore, Jakob Begun, Wei Lian Tan et al.|Journal of Crohn s and Colitis|2023Cited by 61
Upadacitinib induction is effective and safe in ulcerative colitis patients including those with prior exposure to tofacitinib: a multicenter real-world cohort studyRobert Gilmore, Jakob Begun, Richard Fernandes et al.|Intestinal Research|2024Cited by 13
Refractory fulminant colitis following ocrelizumab therapy requiring colectomy in a patient with multiple sclerosisReuben Malloy, Yoon‐Kyo An, Richard Fernandes et al.|BMJ Case Reports|2022Cited by 8
Point‐of‐Care Intestinal Ultrasound Impacts Inflammatory Bowel Disease Care and Reduces the Need for Additional InvestigationsWeiqi Tan, Jakob Begun, Emi Khoo et al.|Journal of Gastroenterology and Hepatology|2025Cited by 5
P1029 Janus Kinase Inhibitors for the Management of Acute Severe Ulcerative Colitis: A Multicentre StudyRobert Gilmore, Yoon‐Kyo An, Richard Fernandes et al.|Journal of Crohn s and Colitis|2025Cited by 3